Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT05483426
Other study ID # 2022-A00342-41
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date August 1, 2022
Est. completion date August 1, 2024

Study information

Verified date July 2022
Source Federation Regionale de Recherche en Psychiatrie et Sante Mentale Occitanie
Contact Julien JD Da Costa, MD
Phone 05 61 14 90 10
Email julien.da-costa@ch-marchant.fr
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Sexual addiction, also known as hypersexuality or compulsive sexuality, is a human sexual behavior that results in a continuous and persistent search for sexual pleasure. Replacing the former terms satyriasis and nymphomania, the World Health Organization (WHO) ICD-11 has referred to this disorder as "compulsive sexual behavior disorders". From multiple causes (iatrogeny, neurological causes, psychiatric causes, psychopathological hypotheses), but still only partially known, the inclusion of this disorder among impulsivity-related disorders, obsessive-compulsive disorders or addiction-related disorders is still debated in the scientific literature. Thus, in the absence of sufficient robust scientific data, DSM-5 refused to include this disorder in its classification. However, the consequences of this disorder on the psychosocial functioning of individuals are not negligible, which can go as far as the precipitation of a transition to an heteroaggressive act which can thus lead to incarceration. The prevalence of this disorder in the general population is estimated between 2 and 6% based on current literature data. This rate appears to be higher among men and more specifically among sex offenders. However, some authors have noted that the difficulty in determining a clear prevalence of sexual addiction may be related to the still poorly defined diagnostic criteria for this disorder as well as the choice of measurement tools. In the inmate population, to our knowledge, there are no French prevalence studies of this disorder. In addition, no studies have been conducted to compare the prevalence of sexual addiction among sex offenders (SASO) with that among non-sex offenders (SANSO). We hope that better screening for addiction would enable better management of patients with this disorder, promoting their psychosocial rehabilitation and well-being, so as to prevent the recurrence of a transition to sexual arousal.


Description:

This study is intended to assess the prevalence of sexual addiction among a population of detainees at the Muret detention center in Haute-Garonne.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 200
Est. completion date August 1, 2024
Est. primary completion date August 1, 2022
Accepts healthy volunteers No
Gender Male
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria: - Male subjects - Detainees at Muret Detention Center - Aged between 18 and 65 at the time of the search - And having agreed to participate in the research. Exclusion Criteria: - Person under legal protection, guardianship or curatorship ; - Insufficient command of the French language - Existence of cognitive disorders preventing a good understanding of the information relating to the study or the various questionnaires.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
semi-structured Interviews
semi-structured interview conducted by a psychiatrist

Locations

Country Name City State
France Julien DA COSTA Toulouse

Sponsors (1)

Lead Sponsor Collaborator
Federation Regionale de Recherche en Psychiatrie et Sante Mentale Occitanie

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary The main objective is to determine the prevalence of sexual addiction among a population of men incarcerated at the Muret detention center in Haute-Garonne. The primary endpoint is the presence of a patient's sexual addiction defined by a score greater than 13 on the Carnes screening test. Day 1
Secondary Determine the prevalence of sexual addiction in a population of sexual offenders The distribution of the proportions of people with sexual addiction is defined by a score greater than 13 on the Carnes screening test in two population groups, perpetrators of sexual offenses and perpetrators of non-sexual offenses. Day 1
Secondary Determine the prevalence of sexual addiction in a population of non-sexual offenders The distribution of the proportions of people with sexual addiction is defined by a score greater than 13 on the Carnes screening test in two population groups, perpetrators of sexual offenses and perpetrators of non-sexual offenses. Day 1
Secondary Compare the prevalence of sexual addiction in these two populations The distribution of the proportions of people with sexual addiction is defined by a score greater than 13 on the Carnes screening test in two population groups, perpetrators of sexual offenses and perpetrators of non-sexual offenses. Day 1
Secondary Determine any addictive and psychiatric co-morbidities associated with each population The presence of psychiatric disorders is defined using the Mini International Neuropsychiatric Interview (MINI) scale. Day 1
See also
  Status Clinical Trial Phase
Recruiting NCT05861752 - Paraphilic Disorders and Other Conditions With Risk for Sexual Violence: a Case-control Study
Not yet recruiting NCT04923451 - tDCS in Treatment of Craving in Sexual Addiction N/A
Enrolling by invitation NCT02844985 - A Study of Gene Polymorphisms Associated With Specific Presentations of Sexual Addiction